Has Uzma Azfar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,769 in general payments to Uzma Azfar, MD across 18 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Uzma Azfar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Uzma Azfar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Uzma Azfar, MD

Foot & Ankle Surgery · Richmond Hill, NYNPI 1497216253

Payments from drug & device makers

$1,769in general payments, 2019–2025

Across 18 payments — averaging $98.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gotham Surgical Solutions & Devices, Inc.$1K
Stryker$170
AbbVie$124
Bioventus LLC$117
Polaris Technology Solutions LLC$63
Osteomed LLC$45
plus $37 from 2 others

What the payments were for

Food & beverage$56932%
Education$1,20068%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gotham Surgical Solutions & Devices, Inc.	2	$1,213
Stryker	3	$170
AbbVie	5	$124
Bioventus LLC	2	$117
Polaris Technology Solutions LLC	3	$63
Osteomed LLC	1	$45
Smith+Nephew	1	$20
Cumberland Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VARIAX$130

How this compares

$1,769 in reported general payments places this provider in the 45th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York →

Medicare billing

Part B allowed, 2024

$10,422

Medicare patients

Services billed

103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxepin Hcl	53	$13,035
Clotrimazole	148	$6,497
CiclopiroxCiclopirox Olamine	40	$4,235
Betamethasone Dipropionate	20	$1,826
Gabapentin	46	$420
Terbinafine Hcl	16	$206
Meloxicam	25	$76
Amoxicillin	22	$51

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Richmond Hill

James McWilliamHarrison$4.7M
Jonathan DelandNew York$4.1M
George Vitole Roy$2.5M
Constantine DemetracopoulosNew York$888K
Anne JohnsonNew York$815K
Scott EllisNew York$644K
John KennedyNew York$613K
Michael KellerKingston$532K
Judith BaumhauerRochester$365K
Edward AzarBrooklyn$224K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →